This award celebrates scientists who have made significant contributions to human healthcare.

The RISE Fellows at Drew University have selected Amgen’s drug discovery program of LUMAKRAS (sotorasib) as recipients of Drew University’s “Heroes in Drug Discovery” award based on the discovery of the first FDA approved KRAS inhibitor for the treatment of cancer.

For more information or to register: https://drew.edu/heroes